We are live on !
Find out more
Spirepoint Private Client Portfolio holdings
AUM
$1.23B
Turnover
11.53%
1-Year Est. Return
30.73%
This Fund
S&P 500
This Quarter Est. Return
+18.12%
1 Year Est. Return
+30.73%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.23B
AUM Growth
+$183M
(+17%)
Cap. Flow
+$67.1M
Cap. Flow % of AUM
Cap. Flow %
5.43%
Top 10 Holdings %
Top 10 Hldgs %
36.34%
Holding
347
New
25
Increased
132
Reduced
118
Closed
15
Avg Time Held
1.4
years
Top 10 Avg Time Held
1.3
years
Top 20 Avg Time Held
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Semiconductor ETF
SOXX
|
+$13.4M |
| 2 |
Arista Networks
ANET
|
+$10.4M |
| 3 |
TSMC
TSM
|
+$9.29M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$8.41M |
| 5 |
Chubb
CB
|
+$6.94M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$7.95M |
| 2 |
Boston Scientific
BSX
|
+$5.38M |
| 3 |
AbbVie
ABBV
|
+$4.88M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$4.53M |
| 5 |
Ares Management
ARES
|
+$3.97M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.75% |
| 2 | Miscellaneous | 19.94% |
| 3 | Industrials | 17.92% |
| 4 | Financials | 7.19% |
| 5 | Consumer Discretionary | 6.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
301
State Street SPDR S&P Dividend ETF
SDY
$22B
| $250K | 0.02% |
1,645
| – | – |
2025 Q4
2 quarters
|
|
302
Marsh
MRSH
$94.2B
| $250K | 0.02% |
1,501
-60
| -4% | -$10K |
2024 Q1
9 quarters
|
|
303
Alibaba
BABA
$248B
| $249K | 0.02% |
2,594
-19
| -0.7% | -$2.38K |
2025 Q3
3 quarters
|
|
304
Aon
AON
$64.4B
| $245K | 0.02% |
740
+5
| +0.7% | +$1.61K |
2024 Q1
9 quarters
|
|
305
LPL Financial
LPLA
$24.9B
| $242K | 0.02% |
859
-37
| -4% | -$11.1K |
2025 Q3
3 quarters
|
|
306
Allegion
ALLE
$15.2B
| $241K | 0.02% |
1,715
-50
| -3% | -$6.8K |
2025 Q3
3 quarters
|
|
307
Emcor
EME
$28.6B
| $240K | 0.02% |
289
| – | – |
2026 Q1
1 quarter
|
|
308
Verizon
VZ
$186B
| $238K | 0.02% |
5,618
-1,039
| -16% | -$48.7K |
2024 Q1
9 quarters
|
|
309
CVS Health
CVS
$120B
| $230K | 0.02% |
+2,222
| New | +$198K |
2026 Q2
0 quarters
|
|
310
Fifth Third Bancorp
FITB
$48B
| $228K | 0.02% |
+4,052
| New | +$205K |
2026 Q2
0 quarters
|
|
311
Aflac
AFL
$60.4B
| $226K | 0.02% |
1,927
-85
| -4% | -$9.8K |
2024 Q1
9 quarters
|
|
312
iShares MSCI Israel ETF
EIS
$869M
| $223K | 0.02% |
1,850
| – | – |
2025 Q4
2 quarters
|
|
313
Travelers Companies
TRV
$83.1B
| $223K | 0.02% |
674
-187
| -22% | -$56.7K |
2025 Q3
3 quarters
|
|
314
Incyte
INCY
$23.5B
| $222K | 0.02% |
+1,954
| New | +$194K |
2026 Q2
0 quarters
|
|
315
Yum! Brands
YUM
$40.9B
| $217K | 0.02% |
1,360
-32
| -2% | -$4.96K |
2025 Q1
5 quarters
|
|
316
Vertex Pharmaceuticals
VRTX
$133B
| $215K | 0.02% |
+433
| New | +$192K |
2026 Q2
0 quarters
|
|
317
PIMCO Dynamic Income Strategy Fund
PDX
$909M
| $215K | 0.02% |
10,321
| – | – |
2025 Q4
2 quarters
|
|
318
Realty Income
O
$53.8B
| $214K | 0.02% |
3,448
-7
| -0.2% | -$436 |
2026 Q1
1 quarter
|
|
319
Simon Property Group
SPG
$68.5B
| $209K | 0.02% |
+933
| New | +$192K |
2026 Q2
0 quarters
|
|
320
TE Connectivity
TEL
$60.2B
| $208K | 0.02% |
1,033
+10
| +1% | +$2.13K |
2025 Q3
3 quarters
|
|
321
Phillips 66
PSX
$113B
| $206K | 0.02% |
1,221
| – | – |
2026 Q1
1 quarter
|
|
322
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.2B
| $205K | 0.02% |
+1,035
| New | +$200K |
2026 Q2
0 quarters
|
|
323
abrdn Total Dynamic Dividend Fund
AOD
$1.05B
| $204K | 0.02% |
19,780
+166
| +0.8% | +$1.7K |
2025 Q3
3 quarters
|
|
324
DoubleLine Yield Opportunities Fund
DLY
$636M
| $186K | 0.02% |
13,250
| – | – |
2025 Q4
2 quarters
|
|
325
BlackRock Health Sciences Trust II
BMEZ
$1.05B
| $160K | 0.01% |
10,436
| – | – |
2025 Q4
2 quarters
|
|
Similar funds
Spirepoint Private Client's Q2 2026 Portfolio in Review
As of Q2 2026, Spirepoint Private Client held 347 positions worth $1.23B, up 17% from $1.05B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Spirepoint Private Client deployed $67.1M of net new capital in Q2 2026, opening 25 new positions and adding to 132 existing holdings. Its largest new stake was iShares Semiconductor ETF: 26,384 shares worth $16.9M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 22% a quarter earlier, followed by Miscellaneous and Industrials.
On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $7.95M trimmed.
- Spirepoint Private Client's largest Q2 2026 buy was iShares Semiconductor ETF: 26,384 shares worth $16.9M.
- Spirepoint Private Client added most to Arista Networks in Q2 2026, an estimated $10.4M increase.
- Spirepoint Private Client's biggest Q2 2026 reduction was Thermo Fisher Scientific, cutting an estimated $7.95M.
- Spirepoint Private Client fully exited Ares Management in Q2 2026, selling an estimated $3.97M.
- Spirepoint Private Client's ten largest holdings make up 36% of its $1.23B portfolio in Q2 2026.
- Spirepoint Private Client opened 25 new positions and closed 15 in Q2 2026.
- Spirepoint Private Client's portfolio value rose 17% quarter-over-quarter to $1.23B.
Based on Spirepoint Private Client's 13F filing for Q2 2026, filed 5 Aug 2026.